Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke

Abstract EN

Stroke is a leading cause of mortality worldwide, as well as a source of long-term disabilities and huge socioeconomic costs.

This study investigates the effects of resveratrol, an antioxidant supplement, on blood pressure, weight status, glucose, and lipid profile in patients who had a stroke in the last 12 months.

Two hundred and twenty-eight patients were divided into three groups: group I received only allopathic treatment (control group), while groups II and III received allopathic treatment with a daily supplementation of oral resveratrol (100 and 200 mg, resp.) for 12 months.

In all groups, the changes of the studied parameters were monitored at 6 and 12 months from the initial evaluation.

In groups II and III, resveratrol induced significant changes (p<0.05) in the blood pressure, body mass index, as well as all parameters of the lipid profile, and glucose (in nondiabetic patients), compared to the control group.

The supplementation of the allopathic treatment with resveratrol had a beneficial effect on all monitored parameters, which serve as major risk factors for stroke.